Skip to content

Clinical trials

Phase 1/2 Epilepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 1/2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20102
20111
20121
20141
20191
20201
20211
20221
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Active, not recruiting1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Medical Center, Cincinnati3
Achelios Therapeutics1
Aquestive Therapeutics1
Johns Hopkins University1
Longboard Pharmaceuticals1
NaviFUS Corporation1
Neurelis, Inc.1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Praxis Precision Medicines1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy15
Seizures3
Tuberous Sclerosis3
Bipolar Disorder1
Central Nervous System Diseases1
Drug Resistant Epilepsy1
Dyslipidemias1
Epilepsies, Myoclonic1
Epilepsies, Partial1
Epileptic Syndromes1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.